Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.80    0.00 (0.00%)
Bid:
64.00
Ask:
68.20
Spread: 4.20 (6.563%)
Market Cap: £111.39m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Total Voting Rights & Additional Listing

1 Aug 2017 11:18

RNS Number : 7433M
GCP Asset Backed Income Fund Ltd
01 August 2017
 

 

GCP Asset Backed Income Fund Limited

("GCP Asset Backed" or the "Company")

LEI 213800FBBZCQMP73A815

Total Voting Rights & Additional Listing

 1 August 2017

GCP Asset Backed, which invests in asset backed loans, today announces that following the Conversion of C shares, the admission to listing on the Premium Listing segment of the Official List of the UK Listing Authority and commencement in dealings on the London Stock Exchange's Main Market for listed securities of 78,177,589 ordinary shares and the cancellation of C shares occurred at 8.00 a.m. today.

In conformity with the FCA's Disclosure Guidance and Transparency Rules, the Company would like to notify the market of the following.

As at 1 August 2017, the Company will have 242,789,672 ordinary shares in issue and therefore the total voting rights in the Company will be 242,789,672.

The figure 242,789,672 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company, under the FCA's Disclosure and Transparency Rules.

Terms used in this announcement shall have the same meanings given to them in the prospectus of the Company which was published on 20 January 2017 unless the context otherwise requires.

 

For further information please contact:

 

Gravis Capital Management Limited

+ 44 (0) 20 3405 8500

David Conlon

david.conlon@gcpuk.com

Philip Kent

philip.kent@gcpuk.com

Dion Di Miceli

dion.dimiceli@gcpuk.com

 

Cenkos Securities plc

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

Oliver Packard

opackard@cenkos.com

Sapna Shah

sshah@cenkos.com

 

Buchanan

+44 (0)20 7466 5000

Charles Ryland

charlesr@buchanan.uk.com

Vicky Hayns

victoriah@buchanan.uk.com 

Notes to Editors

The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSPBMMTMBBMBAR
Date   Source Headline
3rd Feb 20227:00 amRNSCo-living Group Loan Update
31st Jan 20227:00 amRNSInvestor Report at 31 December 2021
27th Jan 20227:00 amRNSDividend Declaration
25th Jan 20227:00 amRNSNet Asset Value and Investment Update
22nd Dec 20219:03 amRNSCo-Living 2021 Year End Update
3rd Nov 20217:00 amRNSDividend Declaration
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
15th Oct 20217:00 amRNSNet Asset Value and Investment Update
28th Sep 20217:00 amRNSHalf-year Report
16th Sep 20217:00 amRNSCo-living Group Loan Update
13th Sep 20217:00 amRNSCo-living Group Loan Update and Net Asset Value
20th Aug 20217:00 amRNSExtension to term of Revolving Credit Facility
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021
22nd Jul 20217:00 amRNSDividend Declaration
15th Jul 20217:00 amRNSNet Asset Value and Investment Update
17th May 20212:13 pmRNSResults of Annual General Meeting
4th May 20217:00 amRNSInvestor Report at 31 March 2021
29th Apr 20215:42 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSDividend Declaration
20th Apr 20217:00 amRNSNet Asset Value and Investment Update
16th Apr 20217:00 amRNSNotice of Annual General Meeting
31st Mar 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAnnual Report & Financial Statements
18th Mar 20217:00 amRNSTransaction in Own Shares
15th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSTransaction in Own Shares
10th Mar 20217:00 amRNSTransaction in Own Shares
8th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
29th Jan 20217:00 amRNSInvestor Report at 31 December 2020
26th Jan 20217:00 amRNSDividend Declaration & Scrip Dividend Suspension
18th Jan 20217:00 amRNSNet Asset Value and Investment Update
4th Dec 20207:00 amRNSInvestment Manager change of control
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSSpecial Dividend Declaration
5th Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSInvestor Report at 30 September 2020
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares
19th Oct 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value and Investment Update
15th Oct 20207:00 amRNSTransaction in Own Shares
12th Oct 20207:00 amRNSTransaction in Own Shares
8th Oct 20207:00 amRNSTransaction in Own Shares
7th Oct 20207:00 amRNSTransaction in Own Shares
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.